HI SB504 | 2018 | Regular Session

Note: Carry Over of previous SB504

Status

Spectrum: Partisan Bill (Democrat 12-0)
Status: Introduced on January 20 2017 - 25% progression, died in committee
Action: 2017-11-30 - Carried over to 2018 Regular Session.
Pending: Senate Commerce, Consumer Protection, and Health Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Limits initial prescriptions for opioids and benzodiazepines to a maximum of seven consecutive days.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating To Controlled Substances.

Sponsors


History

DateChamberAction
2017-11-30 Carried over to 2018 Regular Session.
2017-01-31SenateRe-Referred to CPH.
2017-01-30SenateThe committee(s) on PSM deleted the measure from the public hearing scheduled on 01-31-17 1:15PM in conference room 229.
2017-01-27SenateThe committee(s) on PSM has scheduled a public hearing on 01-31-17 1:15PM in conference room 229.
2017-01-23SenateReferred to PSM, CPH.
2017-01-23SenatePassed First Reading.
2017-01-20SenateIntroduced.

Same As/Similar To

HB666 (Same As) 2018-01-17 - Re-referred to HHS, JUD, referral sheet 1
SB504 (Carry Over) 2017-01-31 - Re-Referred to CPH.

Subjects


Hawaii State Sources


Bill Comments

feedback